Novus Therapeutics, Inc.

( )
NVUS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.17%144.680.7%$944.72m
PFEPfizer Inc. -0.58%35.790.9%$902.06m
MRKMerck & Co., Inc. 0.65%83.170.7%$696.87m
ABBVAbbVie, Inc. -1.41%85.911.9%$656.71m
BMYBristol-Myers Squibb Co. -1.25%58.251.0%$613.93m
LLYEli Lilly & Co. -0.55%148.991.1%$561.72m
AZNAstraZeneca Plc -2.68%54.171.2%$245.65m
NVSNovartis AG -1.32%86.300.2%$163.74m
GSKGlaxoSmithKline Plc -1.11%37.370.2%$104.98m
PRNBPrincipia Biopharma, Inc. 0.00%99.950.0%$80.20m
NVONovo Nordisk A/S -1.59%68.300.1%$57.05m
SNYSanofi 0.36%50.790.2%$49.34m
RGENRepligen Corp. -1.71%139.947.1%$47.54m
RPRXRoyalty Pharma Plc -3.71%40.230.2%$46.64m
OPKOPKO Health, Inc. 0.66%3.0711.2%$43.63m

Company Profile

Novus Therapeutics Inc. engages in the research and development of pharmaceutical products for patients with disorders of the ear, nose, and throat. The company operates under the surfactant and foam platforms. The surfactant platform develops a treatment option for otitis media under OP0201 pipeline. The foam platform is used as a delivery vehicle for drugs to be administered into the ear canals, as well as the nasal and sinus cavities. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.